http://www.patentbaristas.com/archives/2007/06/07/do-authorized-generic-drugs-deter-paragraph-iv-certifications/?utm_source=rss&utm_medium=rss&utm_campaign=do-authorized-generic-drugs-deter-paragraph-iv-certifications Freshly Brewed Bio/Pharma Chat. Served Up Daily. Tue, 07 Feb 2012 11:57:58 +0000 hourly 1 http://wordpress.org/?v=3.3.1 http://www.patentbaristas.com/archives/2007/06/07/do-authorized-generic-drugs-deter-paragraph-iv-certifications/comment-page-1/#comment-13172 Biotech Blog » Carnival of Biotechnology Thu, 28 Jun 2007 15:32:01 +0000 http://www.patentbaristas.com/archives/2007/06/07/do-authorized-generic-drugs-deter-paragraph-iv-certifications/#comment-13172 [...] Regulatory The http://www.patentbaristas.com/”>Patent Baristas report on a report asking Do Authorized Generics Deter Paragraph IV Certifications? Authorized generics are generic drugs sold indirectly through branded drug developers — effectively allowing innovators to compete with generics. A generic drug producer who successfully challenges an innovator’s patent is granted 180 days of marketing exclusivity under a paragraph IV certification. Because innovators can indirectly compete with generics through authorized generics (confused yet), the question at hand is: does this tactic discourage generic drug producers from challenging innovator patents in search of a 180-day marketing exclusivity? [...] [...] Regulatory The http://www.patentbaristas.com/”>Patent Baristas report on a report asking Do Authorized Generics Deter Paragraph IV Certifications? Authorized generics are generic drugs sold indirectly through branded drug developers — effectively allowing innovators to compete with generics. A generic drug producer who successfully challenges an innovator’s patent is granted 180 days of marketing exclusivity under a paragraph IV certification. Because innovators can indirectly compete with generics through authorized generics (confused yet), the question at hand is: does this tactic discourage generic drug producers from challenging innovator patents in search of a 180-day marketing exclusivity? [...]

]]>